AnalystsLaura SutcliffeLaura Sutcliffe's Stock Forecasts
AnalystsLaura Sutcliffe
Analyst Ranking
Bottom 14%
#4785 out of 5548 analysts
Average Return
-6.82%
Win Rate
36%4 out of 11
Risk vs Reward
Poor
Good
Laura Sutcliffe's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Telix Pharmaceuticals LtdTLX | +45.54% | $6.56 | $9.54 | 2026-02-24 - 2026-10-22 | Strong Buy |
Telix Pharmaceuticals LtdTLX | +36.52% | $9.16 | $12.51 | 2025-09-18 - 2026-09-17 | Strong Buy |
Argenx SeARGX | +9.99% | $318.16 | $349.96 | 2021-06-18 - 2022-06-17 | Strong Buy |
Resmed IncRMD | +2.99% | $192.74 | $198.50 | 2026-06-15 - 2026-07-13 | Strong Buy |
Laura Sutcliffe Analyst Color
Get additional color on Laura Sutcliffe's coverage of popular stocks
Laura Sutcliffe's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Resmed IncRMD | 7 | Hold | $235.00 | -7.14% | Downgrades | 3 months ago |
Telix Pharmaceuticals LtdTLX | 4 | Strong Buy | $22.00 | +130.61% | Maintains | 4 months ago |
Banco Santander SaSAN | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Ucb SaUCBJY | 1 | Strong Buy | N/A | N/A | Upgrades | 5 years ago |
Argenx SeARGX | 1 | Strong Buy | $390.00 | N/A | Initiates Coverage On | 5 years ago |
Vifor Pharma AgGNHAF | 1 | Hold | N/A | N/A | Upgrades | 6 years ago |
Lakefront Biotherapeutics NvLKFT | 1 | Hold | N/A | N/A | Downgrades | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.